Durability of the Efficacy and Safety of Dolutegravir-Based and Low-Dose Efavirenz-Based Regimens for the Initial Treatment of Human Immunodeficiency Virus Type 1 Infection in Cameroon: Week 192 Data of the NAMSAL-ANRS-12313 Study
Mpoudi-Etame, Mireille, Tovar Sanchez, Tamara, Bousmah, Marwân-Al-Qays, Omgba Bassega, Pierrette, Olinga, Justin, Mimbe, Eric, Foalem, Michel, Chiep, Camille, Edimo, Serge, Varloteaux, Marie, Pelloquin, Raphaël, Lamare, Nadine, Boyer, Sylvie, Peeters, Martine, Reynes, Jacques, Calmy, Alexandra, Hill, Andrew, Delaporte, Eric, Kouanfack, Charles
Published in Open forum infectious diseases (01.12.2023)
Published in Open forum infectious diseases (01.12.2023)
Get full text
Journal Article